Language

Medicine shortages: Belgium · Page 15

Official notices covering supply interruptions, limited availability and resumed supply. Each notice identifies the product, active ingredient, status and reported period.

Data checked:

1530 notices · Page 15 / 31

← Europe overview

National authority sources: Belgium

Recorded notices include resolved cases. The data check date differs from the modification date of an individual authority notice.

Medicine shortages: Belgium · Page 15

Belgium

Sumatriptan Sandoz 50 mg tabl. 6

Nicht verfügbar · Increased demand
Active ingredient: Sumatriptan

Notice details →
Belgium

Tardyferon 80 mg tabl. prol.-rel. 100

Available again · Not specified
Active ingredient: Iron

Notice details →
Belgium

Airomir Autohaler 100 µg press. inhal. susp. multidos. cont. 200 doses

Available again · Not specified
Active ingredient: Salbutamol

Notice details →
Belgium

Cyclogyl 1 % eye drops sol. dropper cont. 10 ml

Marketing ended · Replacement by another medicinal product/pack
Active ingredient: Cyclopentolate Hydrochloride

Notice details →
Belgium

Dalacin C 600 mg/4 ml inj. sol. i.m./i.v. amp. 5 x 4 ml

Available again · Not specified
Active ingredient: Clindamycin

Notice details →
Belgium

Dexmedetomidine Kabi 100 µg/ml inf. sol. (conc.) i.v. vial 10 x 2 ml

Marketing ended · Commercial reasons
Active ingredient: Dexmedetomidine

Notice details →
Belgium

Dimethyl Fumarate Eurogenerics 120 mg hard gastro-resist. caps. 14

Marketing ended · Replacement by another medicinal product/pack
Active ingredient: Dimethyl Fumarate

Notice details →
Belgium

Elvanse 30 mg hard caps. 30

Nicht verfügbar · Increased demand
Active ingredient: Dexamfetamine

Notice details →
Belgium

Fluconazole Viatris 200 mg hard caps. 10

Available again · Not specified
Active ingredient: Fluconazole

Notice details →
Belgium

Fluconazole Viatris 200 mg hard caps. 20

Available again · Not specified
Active ingredient: Fluconazole

Notice details →
Belgium

Gabapentine Sandoz 100 mg hard caps. 100

Nicht verfügbar · Increased demand
Active ingredient: Gabapentin

Notice details →
Belgium

Halcion 0.125 mg tabl. 10

Nicht verfügbar · Manufacturing delay
Active ingredient: Triazolam

Notice details →
Belgium

Memantine Sandoz 20 mg film-coat. tabl. 98

Marketing ended · Sonstige
Active ingredient: Memantine

Notice details →
Belgium

Pradaxa 110 mg hard caps. 60 (60 x 1) UD

Marketing ended · Insufficient demand
Active ingredient: Dabigatran Etexilate

Notice details →
Belgium

Pradaxa 150 mg hard caps. 60

Marketing ended · Commercial reasons
Active ingredient: Dabigatran Etexilate

Notice details →
Belgium

Rifadine 300 mg hard caps. 50

Nicht verfügbar · Increased demand
Active ingredient: Rifampicin

Notice details →
Belgium

Rythmodan 100 mg hard caps. 120

Marketing ended · Commercial reasons
Active ingredient: Disopyramide

Notice details →
Belgium

Rythmodan 250 mg Long Action tabl. prol.-rel. 40

Marketing ended · Commercial reasons
Active ingredient: Disopyramide

Notice details →
Belgium

Siklos 100 mg film-coat. tabl. 60

Available again · Not specified
Active ingredient: Hydroxycarbamide

Notice details →
Belgium

Spiriva Respimat 2.5 µg inhal. sol. cartr. 60 doses (4 ml)

Marketing ended · Insufficient demand
Active ingredient: Tiotropium

Notice details →
Belgium

Symtuza 800 mg - 150 mg - 200 mg - 10 mg (Abacus Medicine) film-coat. tabl. 30

Nicht verfügbar · Sonstige
Active ingredient: Darunavir ,Cobicistat,Emtricitabine,Tenofovir Alafenamide

Notice details →
Belgium

Tadalafil Sandoz 2.5 mg film-coat. tabl. 28 (28 x 1) UD

Marketing ended · Commercial reasons
Active ingredient: Tadalafil

Notice details →
Belgium

Tadalafil Sandoz 20 mg film-coat. tabl. 4 (4 x 1) UD

Marketing ended · Commercial reasons
Active ingredient: Tadalafil

Notice details →
Belgium

Tamsulosine Viatris Pharma 0.4 mg hard caps. modif.-rel. 200

Available again · Not specified
Active ingredient: Tamsulosin Hydrochloride

Notice details →
Belgium

Usymro 45 mg inj. sol. s.c. pre-filled syr. 0.5 ml

Nicht verfügbar · Sonstige
Active ingredient: Ustekinumab

Notice details →
Belgium

Usymro 90 mg inj. sol. s.c. pre-filled syr. 1 ml

Nicht verfügbar · Sonstige
Active ingredient: Ustekinumab

Notice details →
Belgium

Xenetix 350 350 mg I/ml inj. sol. i.v. 100 ml

Marketing ended · Replacement by another medicinal product/pack
Active ingredient: Iobitridol

Notice details →
Belgium

Xenetix 350 350 mg I/ml inj. sol. i.v. 500 ml

Marketing ended · Replacement by another medicinal product/pack
Active ingredient: Iobitridol

Notice details →
Belgium

Zypadhera 210 mg inj. susp. prol.-rel. (pwdr. + solv.) i.m. vial 210 mg + 3 ml

Available again · Not specified
Active ingredient: Olanzapine

Notice details →
Belgium

Zypadhera 300 mg inj. susp. prol.-rel. (pwdr. + solv.) i.m. vial 300 mg + 3 ml

Available again · Not specified
Active ingredient: Olanzapine

Notice details →
Belgium

Zypadhera 405 mg inj. susp. prol.-rel. (pwdr. + solv.) i.m. vial 405 mg + 3 ml

Available again · Not specified
Active ingredient: Olanzapine

Notice details →
Belgium

Aggrastat 0.05 mg/ml inf. sol. i.v. 250 ml

Nicht verfügbar · Delay in final product release
Active ingredient: Tirofiban

Notice details →
Belgium

Alprazolam EG 2 mg (PI Pharma) tabl. 60

Available again · Not specified
Active ingredient: Alprazolam

Notice details →
Belgium

Annaïs Continu 0.02 mg - 3 mg film-coat. tabl. 13 x 28 (24 + 4)

Available again · Not specified
Active ingredient: Drospirenone ,Ethinylestradiol

Notice details →
Belgium

Colistineb 2 10*6 IU nebul. sol. (pwdr.)/inj./inf. sol. (pwdr.) i.v. vial 60 x 2 10*6 IU

Nicht verfügbar · Manufacturing delay
Active ingredient: Colistimethate Sodium

Notice details →
Belgium

Coveram 10 mg - 10 mg tabl. 90

Available again · Not specified
Active ingredient: Amlodipine,Perindopril

Notice details →
Belgium

Etoricoxib AB 120 mg film-coat. tabl. 28

Available again · Not specified
Active ingredient: Etoricoxib

Notice details →
Belgium

Etoricoxib AB 90 mg film-coat. tabl. 98

Available again · Not specified
Active ingredient: Etoricoxib

Notice details →
Belgium

Malarone 250 mg - 100 mg film-coat. tabl. 12

Nicht verfügbar · Manufacturing delay
Active ingredient: Atovaquone,Proguanil Hydrochloride

Notice details →
Belgium

Medrol 4 mg tabl. 30

Nicht verfügbar · Sonstige
Active ingredient: Methylprednisolone

Notice details →
Belgium

Negaban 2 g inj./inf. sol. (pwdr.) i.m./i.v. vial 2 g

Nicht verfügbar · Manufacturing delay
Active ingredient: Temocillin

Notice details →
Belgium

Pauline 2 mg film-coat. tabl. 84 (6 x 14)

Available again · Not specified
Active ingredient: Dienogest

Notice details →
Belgium

Tegretol CR 400 mg tabl. modif.-rel. 50

Available again · Not specified
Active ingredient: Carbamazepine

Notice details →
Belgium

Triplixam 10 mg - 2.5 mg - 5 mg film-coat. tabl. 90 (3 x 30)

Available again · Not specified
Active ingredient: Indapamide,Amlodipine,Perindopril

Notice details →
Belgium

Ultibro Breezhaler 85 µg - 43 µg inhal. pwdr. (hard caps.) 30

Available again · Not specified
Active ingredient: Glycopyrronium,Indacaterol

Notice details →
Belgium

Abiraterone Mylan 1 000 mg film-coat. tabl. 30 (30 x 1) UD

Nicht verfügbar · Manufacturing delay
Active ingredient: Abiraterone

Notice details →
Belgium

Accofil 48 10*6 U/0.5 ml inj./inf. sol. i.v./s.c. pre-filled syr. 5 x 0.5 ml

Nicht verfügbar · Logistikprobleme (Transport, Zoll usw.)
Active ingredient: Filgrastim

Notice details →
Belgium

Adempas 1.5 mg film-coat. tabl. 42

Nicht verfügbar · Manufacturing delay
Active ingredient: Riociguat

Notice details →
Belgium

Aldara 5 % cream sachet 12 x 250 mg

Nicht verfügbar · Excipient not available
Active ingredient: Imiquimod

Notice details →
Belgium

Amlodipine Besilate Viatris 5 mg tabl. 30

Nicht verfügbar · Sonstige
Active ingredient: Amlodipine

Notice details →